Investor Presentation
Investor Presentation September 201720-09-2017
Press Release / Media Release
Zydus and Pharm Aid Ltd., enter into an exclusive agreement for vaccine technology in Russia.19-09-2017
Press Release / Media Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Oseltamivir Powder for Oral Suspension'16-09-2017
Zydus gets two product approvals from USFDA
Cadila Healthcare Ltd (Zydus Cadila) on Friday announced that the company has received final approval from the US drug regulator US Food and Drug Administration (USFDA) to market Modafinil tablets...15-09-2017
USFDA inspection of Cadila plant
Drug firm Cadila Healthcare today said the US health regulator has issued no observations after completion of inspection of its Moraiya plant in Gujarat. The USFDA has inspected the company's...07-09-2017
Clarifies on news item
With reference to news flashed on CNBC TV 18 dated September 7, 2017 quoting "US FDA issues zero observations post re-inspection of Moraiya unit.", Cadila Healthcare Ltd has submitted to BSE a copy of Clarification is enclosed.07-09-2017
Press Release / Media Release
Cadila Healthcare's Moraiya facility successfully completes USFDA inspection07-09-2017
Clarification sought from Cadila Healthcare Ltd
The Exchange has sought clarification from Cadila Healthcare Ltd on September 7, 2017 with reference to news flashed on CNBC TV 18 dated September 7, 2017 quoting "US FDA issues zero observations post re-inspection of Moraiya unit."".The reply is awaited.07-09-2017
Zydus Cadila gets USFDA nod for injection to patients taking organ transplantation
Cadila Healthcare today said its group firm Zydus Cadila has received final approval from the USFDA to market Mycophenolate mofetil for injection used in organ transplants to prevent rejection....02-09-2017